Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas.
Filopanti M, Barbieri AM, Angioni AR, Colao A, Gasco V, Grottoli S, Peri A, Baglioni S, Fustini MF, Pigliaru F, Monte PD, Borretta G, Ambrosi B, Jaffrain-Rea ML, Gasperi M, Brogioni S, Cannavò S, Mantovani G, Beck-Peccoz P, Lania A, Spada A. Filopanti M, et al. Pharmacogenomics J. 2008 Oct;8(5):357-63. doi: 10.1038/tpj.2008.1. Epub 2008 Mar 11. Pharmacogenomics J. 2008. PMID: 18332900
Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification.
Carbonara F, Feola T, Gianno F, Polidoro MA, Di Crescenzo RM, Arcella A, De Angelis M, Morace R, de Alcubierre D, Esposito V, Giangaspero F, Jaffrain-Rea ML. Carbonara F, et al. Among authors: jaffrain rea ml. Endocr Pathol. 2024 Mar;35(1):1-13. doi: 10.1007/s12022-023-09794-w. Epub 2023 Dec 14. Endocr Pathol. 2024. PMID: 38095839 Free PMC article.
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study.
Filopanti M, Olgiati L, Mantovani G, Corbetta S, Arosio M, Gasco V, De Marinis L, Martini C, Bogazzi F, Cannavò S, Colao A, Ferone D, Arnaldi G, Pigliaru F, Peri A, Angeletti G, Jaffrain-Rea ML, Lania AG, Spada A. Filopanti M, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):E165-72. doi: 10.1210/jc.2011-1769. Epub 2011 Dec 7. J Clin Endocrinol Metab. 2012. PMID: 22162472 Clinical Trial.
The prevalence of silent acromegaly in prolactinomas is very low.
Bona C, Prencipe N, Jaffrain-Rea ML, Carosi G, Lanzi R, Ambrosio MR, Pasquali D, Vettor R, Cannavò S, Ghigo E, Grottoli S. Bona C, et al. J Endocrinol Invest. 2021 Mar;44(3):531-539. doi: 10.1007/s40618-020-01338-x. Epub 2020 Jun 27. J Endocrinol Invest. 2021. PMID: 32594452
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences.
Chiloiro S, Appetecchia M, Bianchi A, Costa D, De Acetis C, Gargiulo P, Giampietro A, Isidori AM, Jaffrain-Rea ML, Passeri M, Pigliaru F, Poggi M, De Marinis L. Chiloiro S, et al. Among authors: jaffrain rea ml. Drugs Context. 2024 May 20;13:2024-1-2. doi: 10.7573/dic.2024-1-2. eCollection 2024. Drugs Context. 2024. PMID: 38817802 Free PMC article.
Giant prolactinomas presenting as skull base tumors.
Minniti G, Jaffrain-Rea ML, Santoro A, Esposito V, Ferrante L, Delfini R, Cantore G. Minniti G, et al. Surg Neurol. 2002 Feb;57(2):99-103; discussion 103-4. doi: 10.1016/s0090-3019(01)00697-8. Surg Neurol. 2002. PMID: 11904200
92 results